Effect of plasma components on the stability and permeability of microcapsule
Source abstract
Abstract
Abstract Immobilization of hepatocytes in microcapsules has been a potentially alternative methodology for bioartificial livers (BALs). Moreover, the stability and permeability are the key parameters of these microcapsules. However, these alginate‐based microcapsules are unstable if the surrounding medium disrupts the ionic interactions between alginate and the polycation. As hundreds of components are included in human plasma, the stability and permeability in plasma of microcapsules need to be sufficiently investigated. In the present study, the stability of three kinds of alginate‐based microcapsules was evaluated when they were immersed in plasma. Our results showed that stability of alginate‐α‐poly (l‐lysine)‐alginate (α‐APA) microcapsules was well maintained, better than those of alginate‐ε‐poly (l‐lysine)‐alginate (ε‐APA) and alginate–chitosan–alginate (ACA) microcapsules. Also, factors affecting the stability of microcapsules in plasma were analyzed and it showed that heparin was the key factor that affected the stability of α‐APA microcapsules, whereas heparin and low molecular electrolytes such as HCO3− and H2PO4−/HPO42− were the factors to ε‐APA and ACA microcapsules. In addition, the permeability evaluation showed no decrease in permeability of microcapsules after incubation in plasma. Our study might provide a foundation for the selection and modification of materials for microcapsule‐based BAL devices. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 2408–2416, 2014.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Pancreatic function and diabetes · Membrane Separation Technologies · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Laboratory of Biomedical Material Engineering Dalian Institute of Chemical Physics, Chinese Academy of Sciences Dalian 116023 China
University of the Chinese Academy of Sciences Beijing 100049 China
References (43)
Show source-provided references
1. 10.1007/978-1-60761-688-7_2810.1007/978-1-60761-688-7_28 ↗
2. 10.1111/j.1744-9987.2006.00359.x10.1111/j.1744-9987.2006.00359.x ↗
3. 10.1016/j.jchromb.2007.07.04810.1016/j.jchromb.2007.07.048 ↗
4. Support of hepatic biochemical function during hollow fiber bioartificial liver hemoperfusion
5. Bioartificial liver based on hollow fiber membrane: Physical and biological characterization at micro scale level
6. 10.1211/002235702196310.1211/0022357021963 ↗
7. 10.1007/s11684-010-0110-x10.1007/s11684-010-0110-x ↗
8. Microencapsulated hepatocytes as a bioartificial liver
9. 10.1046/j.1526-0968.1999.00152.x10.1046/j.1526-0968.1999.00152.x ↗
10. 10.5754/hge1103410.5754/hge11034 ↗
11. 10.1016/j.biomaterials.2010.01.06810.1016/j.biomaterials.2010.01.068 ↗
12. 10.1038/gt.2011.9410.1038/gt.2011.94 ↗
13. 10.1126/science.176332810.1126/science.1763328 ↗
14. 10.1126/science.677662810.1126/science.6776628 ↗
15. Microcapsule and its applications in biomedical field
16. 10.1016/j.hepres.2006.03.00310.1016/j.hepres.2006.03.003 ↗
17. 10.1002/bit.2292010.1002/bit.22920 ↗
18. A clinical scale bioreactor for extracorporeal bioartificial liver machine using liver‐derived human cells
19. 10.1002/bit.2315010.1002/bit.23150 ↗
20. 10.1097/00003246-200203000-0002710.1097/00003246-200203000-00027 ↗
21. Optimization of chitosan–alginate encapsulation process using pig Hepatocytes for development of bioartificial liver
22. 10.1002/apmc.1993.05212011510.1002/apmc.1993.052120115 ↗
23. 10.2310/6650.2001.3372210.2310/6650.2001.33722 ↗
24. 10.1177/03913988060290080510.1177/039139880602900805 ↗
25. 10.1016/j.carbpol.2006.09.00210.1016/j.carbpol.2006.09.002 ↗
26. 10.1016/S0169-409X(00)00054-510.1016/S0169-409X(00)00054-5 ↗
27. 10.1016/S0142-9612(01)00391-X10.1016/S0142-9612(01)00391-X ↗
28. 10.1002/jbm.a.3303010.1002/jbm.a.33030 ↗
29. 10.1002/bit.26027020710.1002/bit.260270207 ↗
30. 10.1002/jbm.a.3403210.1002/jbm.a.34032 ↗
31. 10.1089/ten.tec.2009.054510.1089/ten.tec.2009.0545 ↗
32. 10.1002/(SICI)1097-0290(19961120)52:4<472::AID-BIT3>3.0.CO;2-M10.1002/(SICI)1097-0290(19961120)52:4<472::AID-BIT3>3.0.CO;2-M ↗
33. Characterization methods for microcapsules
34. 10.1163/15685620175325255210.1163/156856201753252552 ↗
35. 10.1080/02652040500009989310.1080/026520405000099893 ↗
36. 10.1016/S0142-9612(00)00071-510.1016/S0142-9612(00)00071-5 ↗
37. 10.1016/j.jcis.2012.08.00810.1016/j.jcis.2012.08.008 ↗
38. 10.1163/092050610X54642610.1163/092050610X546426 ↗
39. 10.1016/j.biomaterials.2011.10.04810.1016/j.biomaterials.2011.10.048 ↗
40. 10.1021/bm101366210.1021/bm1013662 ↗
41. 10.1016/S0939-6411(03)00161-910.1016/S0939-6411(03)00161-9 ↗
42. 10.1039/c1sm05676j10.1039/c1sm05676j ↗
43. 10.1002/1097-4636(20010305)54:3<396::AID-JBM120>3.0.CO;2-B10.1002/1097-4636(20010305)54:3<396::AID-JBM120>3.0.CO;2-B ↗